Nwus 2008 Conference Agenda

Northwest Urological Society 2008 Agenda Fri Dec 5, 2008 Health Policy Agenda 8:00

Opening Remarks

8:05

Getting Positive Results From your Contract Negotiations

8:30

Employment Law Update for your Practice

9:00

Panel Discussion

9:15

BREAK

9:30

Residency Training Programs and the Future of Urology Recruitment

Tom Hatch, MD NWUS President Naya Keyhayes MPH Jack Cooper JD moderated by Tom Hatch, MD

John Barry MD AUA President

10:00 Legislative Issues Critical to Urology 10:30 Panel Discussion

Jeff Kaufman MD AUA Health Policy Chair AACU Past President

moderator by Mark Uhlman, MD John Barry, MD (AUA President) Jeff Frankel, MD (AACU President-Elect) Jeff Kaufman, MD (AUA Health Policy Chair)

11:05 The Future of Medicine in America

Dr. John Kitzhaber Former Oregon State Governor

11:45 Q & A 12:00 Lunch Scientific Session Agenda 1:00 Opening Remarks

Sia Daneshmand, MD NWUS Program Chair

1:05 Keynote Lecture: Current role of BCG in the Management of Non-invasive Bladder Cancer Donald Lamm, M.D. Vice Chair for Research – Urologic Oncology Department of Urology, Mayo Clinic, Scottsdale, Arizona

1:45 Scientific Session I: Oncology I Podium 1-1 DOES THE ABILITY TO PERFORM RALP EXPAND THE POPULATION OF PATIENTS UNDERGOING SURGERY FOR THE MANAGEMENT OF PROSTATE CANCER?- Abtract # 837 Anthony J Woodruff MD, Erin M Odom MD and John M Corman MD, Seattle, WA

Podium 1-2 PT0 IS NOT BENIGN DISEASE: THERE IS A RISK OF PROGRESSION IN PATIENTS WITH NO CANCER IN RADICAL PROSTATECTOMY SPECIMENS- Abstract # 804 Jennifer L. Gurski, Andrew C. Peterson MD, Timothy C. Brand MD. Madigan Army Medical Center, Tacoma, WA. Podium 1-3 THE COMBINATION OF ANTISENSE OLIGONUCLEOTIDES TARGETING HEAT-SHOCK PROTEIN-27 WITH HTI-286 AS A NOVEL INTRAVESICAL TREATMENT FOR HIGH-GRADE BLADDER CANCER- Abstract # 831 Yoshiyuki Matsui, Boris A. Hadaschik MD, Martin E. Gleave MD and Alan I.SoMD The Prostate Centre at Vancouver General Hospital, Vancouver, BC, Canada Podium 1-4 PERIOPERATIVE MORTALITY FROM RADICAL CYSTECTOMY - A MODERN SERIES- Abstract #835 Matt Ashley B.A., Sia Daneshmand, MD: Oregon Health & Science University, Portland, OR Podium 1-5 FACTORS INFLUENCING CHOICE OF URINARY DIVERSION FOLLOWING RADICAL CYSTECTOMY- Abstract #826 Matt Ashley B.A., Sia Daneshmand, MD: Oregon Health & Science University, Portland, OR Podium 1-6 AORTIC REPLACEMENT DURING POST-CHEMO RETROPERITONEAL LYMPH NODE DISSECTION- Abstract #841 Sia Daneshmand, MD Section of Urologic Oncology, Division of Urology & Renal Transplantation Oregon Health & Science University, Portland, OR

2:30

Break/ View Exhibits

3:00

Scientific Session II: Endourology/ Minimally Invasive Surgery

Podium 2-1 IN-OFFICE LASER VAPORIZATION OF THE PROSTATE- Abstract #809 Gregory B. McCoy, M.D., The Urology Clinic, Portland, Oregon Podium 2-2 USE OF ANTEGRADE SALLE STENT IN LAPAROSCOPIC PYELOPLASTY- Abstract #810 Brian C. Fong, MD: Western Washington Medical Group, Department of Urology, Everett, WA Podium 2-3 HOLMIUM LASER ENUCLEATION OF THE PROSTATE: MULTIMEDIA DESCRIPTION OF TECHNIQUE- Abstract #811 Brian C. Fong, MD: Western Washington Medical Group, Department of Urology, Everett, WA Podium 2-4 PERCUTANEOUS RENAL CRYOABLATION: EARLY RESULTS FROM A PROSPECTIVE DATABASE- Abstract # 825 CB Metcalfe MD, University of British Columbia Department of Urological Sciences. BJ Donnelly MD, University of Calgary Division of Urology. M Welsh MD, University of Calgary Department of Radiology Podium 2-5 WHAT IS THE APPROPRIATE LENGTH OF URETERAL ACCESS SHEATH FOR FLEXIBLE URETEROSCOPY?- Abstract #836 Laura Chang Kit MD, Joel Teichman MD: University of British Columbia; Department of Urology, St Paul’s Hospital, Vancouver, BC Canada Podium 2-6 REDUCTION OF STONE FRAGMENT RETROPULSION WITH ANTIRETROPULSION DEVICES Abstract #823 B. H. Chew MD, L.M. Jonat MD, R. F. Paterson, J. MD, M.H. Teichman MD: University of British Columbia, Vancouver, BC, Canada

Podium 2-7 URETEROSCOPIC LASER ENDOPAPILLOTOMY TO TREAT CHRONIC FLANK PAIN ASSOCIATED WITH PAPILLARY CALCIFICATIONS – Abstract #813 Yehoshua Gdor MD, Stephen Faddegon MD, Ahmed H. Gabr MD, William W. Roberts MD, Gary J. Faerber MD, Joel M.H. Teichman MD, J. Stuart Wolf M, Jr. MD Department of Urology, University of Michigan, Ann Arbor, MI, USA; Dept. of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada Podium 2-8 INTRARENAL ULTRASOUND (IRUS) - A NOVEL TECHNOLOGY TO SIZE KIDNEY STONES DURING URETEROSCOPY- Abstract #802 Mathew D. Sorensen, MD, MS, Michael R. Bailey, PhD: Department of Urology, University of Washington School of Medicine, Seattle, WA

4:15

Point-Counter Point- Management of High Grade T1 Bladder Cancer Donald Lamm, M.D.- BCG Sia Daneshmand, M.D.- Radical Cystectomy

Cases/Discussion

5:00

Adjourn

Saturday Dec 6, 2008 9:00

Scientific Session III: Female Urology/Voiding Dysfunction

Podium 3-1 TRANSURETHRAL RADIOFREQUENCY COLLAGEN DENATURATION- Abstract #821 Denise Elser, MD GK Mitchell, MD; JR Miklos, MD; KG Nickell, MD; K Cline, MD: H Winkler, MD; WG Wells, MD Podium 3-2 DEFINING SUCCESS FOLLOWING SLING SURGERY: ASSOCIATION OF SATISFACTION WITH PATIENT REPORTED OUTCOMES- Abstract #818 David E Rapp MD, Nancy J Neil MD, Alvaro Lucioni MD, Kathleen C Kobashi MD The Continence Center at Virginia Mason Medical Center, Seattle, WA Lifecycle Sciences Group, Icon Clinical Research, San Francisco, CA Podium 3-3 PRE-OPERATIVE URODYNAMIC PARAMETERS DO NOT CORRELATE WITH RESPONSE TO BTX INJECTION IN PATIENTS WITH DETRUSOR OVERACTIVITY- Abstract #816 David E Rapp MD, Alvaro Lucioni MD, Jason Kim MD, W Stuart Reynolds MD, Kathleen C Kobashi MD, Gregory T Bales MD The Continence Center at Virginia Mason Medical Center, Seattle, WA The University of Chicago Hospitals, Chicago, IL Podium 3-4 OUTCOMES FOLLOWING MID-URETHRAL SLING PLACEMENT IN PATIENTS WITH INTRINSIC SPHINCTERIC DEFICIENCY: COMPARISON OF SPARC AND MONARC SLINGS Abstract #817 David E Rapp MD, Alvaro Lucioni MD, Fred E Govier MD, Kathleen C Kobashi MD The Continence Center at Virginia Mason Medical Center, Seattle, WA Podium 3-5 TEST-RETEST RELIABILITY OF REPEATED PRESSURE FLOW URODYNAMIC STUDIES DURING A SINGLE SESSION IN WOMEN- Abstract #815 Justin Lee , Abhishek Seth MD, Ramon Geurro MD, Lynn Stothers MD: Department of Urological Science, University of British Columbia, Vancouver, BC

9:45

Scientific Session IV: Pediatrics

Podium 4-1 THE USE OF PATIENT-ACQUIRED DIGITAL IMAGES FOR POSTOPERATIVE CARE Abstract #828 Van Ginger MD, Thomas Lendvay MD, Byron Joyner MD, Martin Koyle MD: Children’s Hospital & Regional Medical Center, Seattle, WA Podium 4-2 PROGNOSTIC FACTORS IN RESOLUTION OF ANTENATALLY DIAGNOSED HYDRONEPHROSIS: A MULTIVARIABLE ANALYSIS- Abstract #824 M. Longpre MD, D. Yanko MD, S. Jafari MD, K. Afshar MD University of British Columbia Podium 4-3 TECHNIQUE OF UMBILICAL RECONSTRUCTION USING A TWO-FACED FLAP TECHNIQUE Abstract #807 Stephanya Shear, MD MPH , Byron Joyner, M.D., Margarett Shnorhavorian, M.D., M.P.H., Thomas Lendvay, M.D., Martin Koyle, M.D.Richard. W. Grady, M.D.: Children’s Hospital & Regional Medical Center, Seattle, WA

Podium 4-4 URODYNAMIC PROFILE FINDINGS FOLLOWING BLADDER AUTOAUGMENTATION Abstract #808 Jennifer Foti MD, Ismael Zamilpa MD, Thomas Lendvay MD, Richard Grady MD Children's Hospital and Regional Medical Center; Seattle, Washington

10:15

Scientific Session V: Transplant/Infertiltiy

Podium 5-1 GRAFT AND CORRUPTION - THE USE OF ARTIFICIAL VASCULAR GRAFTS IN KIDNEY TRANSPLANTATION- Abstract #830 Christian S. Kuhr MD and Thomas R. Hefty MD: Virginia Mason Medical Center, Seattle, WA Podium 5-2 PREDICTION OF DELAYED GRAFT FUNCTION (DGF) AFTER DECESASED-DONOR RENAL TRANSPLANTATION- Abstract #820 Jason C. Hedges, M.D., Ph.D., J. C. Prather, Ph.D., John M. Barry, M.D. Division of Urology & Renal Transplantation, Oregon Health & Science University Podium 5-3 DURING VASECTOMY REVERSAL SURGERY, THE PROBABILITY OF EPIDIDYMAL BYPASS RATHER THAN VASOVASOSTOMY INCREASES AS TIME FROM VASECTOMY LENGTHENS- Abstract #805 Gregory S. Taylor M.D., Molly E. Fuchs, B.A., Lisa B. Bland, M.D., M.P.H., Eugene F. Fuchs M.D.: Oregon Health & Science University Podium 5-4 DURING VASECTOMY REVERSAL, FINDING ONLY SPERM HEADS IN PROXIMAL VAS FLUID PREDICTS TECHNICAL SUCCESS- Abstract #806 Lisa B. Bland, M.D., M.P.H., Molly E. Fuchs, B.A.*, Eugene F. Fuchs, M.D.: Oregon Health & Science University

10:45

Break/ Exhibit Hall

11:15

State of the Art Lecture: Robotic Renal Surgery

Sam Bhayani, M.D., Co-Director of Robotic Surgery, Assistant Professor of Urology and Surgery, Washington University School of Medicine, St. Louis, MO

12:00

Lunch

1:00

Scientific Session VI: Oncology II

Podium 6-1 TIME TO TREATMENT OF PROSTATE CANCER THROUGH THE CALGARY PROSTATE INSTITUTE RAPID ACCESS CLINIC- Abstract #822 A.G Kavanagh MD, J.C. Lee MD, B. Donnelly MD, University of Calgary Podium 6-2 ARE ROUTINE METASTATIC SURVEYS WARRANTED FOR INTERMEDIATE RISK PROSTATE CANCER? Abstract #819 Andrew Locke, Erin Odom and John M. Corman, M.D.: Virginia Mason Medical Center, Seattle, WA

Podium 6-3 TRANSURETHRAL PROSTATE BIOPSY FOR CANCER DETECTION IN PATIENTS UNDERGOING SERIAL BIOPSIES- Abstract #833

Gregory T. Adams MD, Gregory S. Rosenblatt MD, Shane Rogosin MD, Solange Mongoue-Tchokote MS, Mark Garzotto, MD; Oregon Health & Science University, Portland, OR. Podium 6-4 DIFFERENTIAL TARGET IDENTIFICATION OF STATIN THERAPY IN ANDROGEN – SENSITIVE AND –INSENSITIVE PROSTATE CANCER CELLS- Abstract #834 Mark Garzotto MD, Nicole M. Janeba B.A and Jackilen Shannon PhD. Oregon Health & Science University, Portland, OR. Podium 6-5 EFFECT OF OBESITY ON PSA DENSITY: IMPLICATIONS FOR IMPROVED DETECTION OF PROSTATE CANCER- Abstract #832 Maire Brennan MS, Solange Mongoue-Tchokote PhD, Jackilen Shannon PhD, Motomi Mori, and Mark Garzotto MD. Oregon Health & Science University, Portland OR. Podium 6-6 PHASE I TRIAL OF IPILIMUMAB (IPI) ALONE AND IN COMBINATION WITH RADIOTHERAPY (XRT) IN PATIENTS WITH METASTATIC CASTRATION RESISTANT PROSTATE CANCER (MCRPC)- Abstract #829 TM Beer,1 SF Slovin,2 CS Higano,3 S Tejwani,4 TB Dorff,5 HI Scher,2 I Lowy,6 and the Prostate Cancer Clinical Trials Consortium. 1Oregon Health & Science University, 2Memorial Sloan Kettering Cancer Center, 3University of Washington, 4Henry Ford Health System, 5The Angeles Clinic and Research Institute, 6Medarex, Inc. Podium 6-7 DAVINCI PROSTATECTOMY: RESULTS FROM 500 CONSECUTIVE PATIENTS- Abstract # 840 James Porter MD and Uzay Yasar MD, Swedish Urology Group, Seattle, WA Podium 6-8 ROBOTIC PARTIAL NEPHRECTOMY- Abstract # 839 James Porter, MD ,Swedish Urology Group, Seattle, WA

1:55

Guest Lecture: CT Urography -- Imaging the patient with painless hematuria Larry Chow, M.D., Associate Professor of Radiology, Oregon Health & Science University

2:30

Break/Exhibit Hall

3:00

Scientific Session VII: Miscellaneous

Podium 7-1 THE ADULT TEMPLATE CIRCUMCISION: A NOVEL TECHNIQUE- Abstract #803 Jennifer L. Gurski MD, Brian J. DeCastro MD, Andrew C. Peterson MD Madigan Army Medical Center, Tacoma, WA. Podium 7-2 USE OF AN OMENTAL WRAP IN URETEROLYSIS- Abstract #801 Jason P. Smith, M.D., Eric Reid, M.D., Aaron Bayne, M.D., Stephen Dunn, M.D., Thomas Hatch, M.D. Oregon Health and Sciences University Portland VA Medical Center Podium 7-3 APPENDICEAL SUBSTITUTION FOLLOWING RIGHT PROXIMAL URETER INJURY Abstract #827 Matt Ashley B.A., Sia Daneshmand, MD: Oregon Health & Science University, Portland, OR Podium 7-4 EVALUATION AND TREATMENT OF LOIN PAIN HEMATURIA SYNDROME- Abstract #812 Eric S. Reid, MD and John M. Barry, MD: Division of Urology and Renal Transplantation, Portland, OR Podium 7-5 HUGH HAMPTON YOUNG: FOREFATHER OF AMERICAN UROLOGIC SURGERY Abstract #814 Brian Duty, M.D. Division of Urology & Renal Transplantation, Oregon Health & Science University

3:30

Management of Clinical Stage I Testis Cancer in 2008 -Craig Nichols, M.D., Director, Providence Cancer Center

4:00

Keynote Speaker: Management of Patients with BCG Failure

4:30

Interactive Case Discussions

5:00

Adjourn

Donald Lamm, M.D. Vice Chair for Research – Urologic Oncology Department of Urology, Mayo Clinic Scottsdale, Arizona